Nicolás A. Rey

Nicolás A. Rey

Auto-generated profile, based on publicly available information

Nicolás A. Rey

Department of Chemistry Pontifical Catholic University of Rio de Janeiro (PUC‐Rio) Rio de Janeiro Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
DCDaphne Cukierman
Daphne Cukierman
APAna Beatriz Pinheiro
Ana Beatriz Pinheiro
SCSergio L.P. Castiñeiras-Filho
Sergio L.P. Castiñeiras-Filho
ASAnastácia Sá P. da Silva
Anastácia Sá P. da Silva
MMMarco C. Miotto
Marco C. Miotto
NRNicolás A. Rey
Nicolás A. Rey

17 June 2019 in Inorganic Chemistry
Verified
Journal Article
Closed access
JRJesica Paola Rada
Jesica Paola Rada
BBBeatriz S. M. Bastos
Beatriz S. M. Bastos
LALuciano Anselmino
Luciano Anselmino
Chris Hebert J FrancoChris Hebert J Franco
Chris Hebert J Franco
MLMauricio Lanznaster
Mauricio Lanznaster
NRNicolás A. Rey
Nicolás A. Rey

1 January 2015 in Metallomics
Verified
Journal Article
Open access
PDF file
RHRachel Ann Hauser-Davis
Rachel Ann Hauser-Davis
LFL. V. de Freitas
L. V. de Freitas
DCDaphne Cukierman
Daphne Cukierman
WCW. S. Cruz
W. S. Cruz
MMM. C. Miotto
M. C. Miotto
NRN. A. Rey
N. A. Rey
A non-toxic hydrazone with potential anti-Alzheimer activity: this organic ligand disrupts anomalous metal–Aβ(1–40) interactions, and, thus, seems suitable as a metal-protein attenuating compound.

25 August 2018 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
DCDaphne S. Cukierman
Daphne S. Cukierman
EAElio Accardo
Elio Accardo
RGRosana Garrido Gomes
Rosana Garrido Gomes
AFAnna De Falco
Anna De Falco
MMMarco C. Miotto
Marco C. Miotto
NRNicolás A. Rey
Nicolás A. Rey

11 May 2020 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
DCDaphne Cukierman
Daphne Cukierman
DLDiana F. Lázaro
Diana F. Lázaro
PSPamela Sacco
Pamela Sacco
PFPatrícia R. Ferreira
Patrícia R. Ferreira
RDRenata Diniz
Renata Diniz
NRNicolás A. Rey
Nicolás A. Rey
Although normal aging presents an accumulation of copper and iron in the brain, this becomes more relevant in neurodegeneration. α-Synuclein (α-Syn) misfolding has long been linked with the development of Parkinson's disease (PD). Copper binding promotes aggregation of α-Syn, as well as generalized oxidative stress. In this sense, the use of therapies that target metal dyshomeostasis has been in focus in the past years. Metal–Protein Attenuating Compounds (MPACs) are moderate chelators that aim at disrupting specific, abnormal metal–protein interactions. Our research group has now established that N-acylhydrazones compose a set of truly encouraging MPACs for the bioinorganic management of metal-enhanced aggregopathies. In the present work, a novel ligand, namely 1-methyl-1H-imidazole-2-carboxaldehyde isonicotinoyl hydrazone (X1INH), is reported. We describe solution studies on the interaction and affinity of this compound for copper(II) ions showing that a fine tuning of metal-affinity was achieved. A series of in vitro biophysical NMR experiments were performed in order to assess the X1INH ability to compete with α-Syn monomers for the binding of both copper(I) and copper(II) ions, which are central in PD pathology. A preference for copper(I) has been observed. X1INH is less toxic to human neuroglioma (H4) cells in comparison to structure-related compounds. Finally, we show that treatment with X1INH results in a higher number of smaller, less compact inclusions in a well-established model of α-Syn aggregation. Thus, X1INH constitutes a promising MPAC for the treatment of Parkinson's disease.